Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00258609
Status:
COMPLETED
Last Update Posted:
2019-02-18
First Post:
2005-11-23
Brief Title:
Dysport In Migraine Without Aura Prophylaxis DIMWAP Study
Sponsor:
Rajavithi Hospital
Organization:
Rajavithi Hospital
Study Overview
Official Title:
A 12-week Prospective Double-blinded Randomized Multicenter Study of Low Dose and Medium Dose Botulinum Toxin Type A Dysport Injection for Migraine Prophylaxis
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether 120 Unit and 240 unit of botulinum toxin A are effective in the treatment of migraine without aura prophylaxis
Detailed Description:
This is a 12-week prospective double-blinded randomized multicenter study of placebo 120 Unit and 240 unit of botulinum toxin A Dysport injection for patient with a diagnosis of Migraine without aura according to International Headache Society criteria It is designed to evaluate the efficacy safety tolerability and optimum dose of Botulinum toxin type A Dysport injection for migraine without aura prophylaxis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None